AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
13min chapter
Novel developments in lower-risk MDS & important practical considerations when treating patients
VJHemOnc Podcast
Innovative Treatments for Anemic Lower-Risk MDS
This chapter explores the current strategies for treating anemic lower-risk myelodysplastic syndromes (MDS) patients, particularly focusing on erythropoiesis-stimulating agents (ESAs) and the emerging use of Luspatercept. The discussion highlights the nuances of treatment decisions based on individual patient characteristics, EPO levels, and transfusion dependence, while comparing practices in Europe and the U.S. Additionally, the chapter examines ongoing trials and the potential implications of adjusting current treatment protocols.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode